| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.00011 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.00011 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 6.6e-05 | 1 |